Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries reported second quarter 2021 financial results on July 28, 2021. The presentation includes forward-looking statements regarding competitive pressures in generics and specialty pharmaceuticals, debt management, and business optimization efforts. Key product lines discussed include AUSTEDO, AJOVY, and COPAXONE amid regulatory and market challenges.
investor_presentation
77 Pages
earnings
28 Pages
Unknown
United Internet AG H1 2023 Results
earningsearnings
32 Pages
UNITED INTERNET
Hong Leong Financial Group 1H FY24 Earnings Results Presentation
earningsearnings
24 Pages
Hong Leong Financial Group Berhad